Is there clinical value in measuring suPAR levels in FSGS?

Clin J Am Soc Nephrol. 2013 Aug;8(8):1273-5. doi: 10.2215/CJN.06170613. Epub 2013 Jul 25.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Female
  • Glomerulosclerosis, Focal Segmental / blood*
  • Humans
  • Male
  • Receptors, Urokinase Plasminogen Activator / blood*

Substances

  • Receptors, Urokinase Plasminogen Activator